// App-Quantinova.ai

e23065 : Identification of APE1 as a chemotherapeutic prognostic marker for non-small cell lung cancer patients.

Researchers

Presenter

  • Mengxia Li

Principal Investigators

  • Dong Wang

  • Shiheng Zhang

  • Le He

  • Nan Dai

Medical Centers

  • Cancer Center of Daping Hospital, Third Military Medical University, Chongqing, China

  • Third Military Medical University, Third Hospital Affiliated, Chongqing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Apurinic/Apyrimidinic Endodeoxyribonuclease 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final